Syros Pharmaceuticals, Inc.
Market Cap
$5.37K
P/E Ratio
—
EPS
$-0.77
Dividend Yield
0.00%
52-Week Range
$0.00 — $0.12
Volume
904
Avg Volume
29.28K
Beta
1.31
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.00
P/B (TTM)
0.00
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-2.28%
ROA (TTM)
-0.98%
ROIC
—
Gross Margin
0.77%
Operating Margin
-12.98%
Net Margin
—
Debt/Equity
3.73
Current Ratio
3.95
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.31%
EPS Growth (5Y)
+0.19%
Sales Growth (3Y)
-0.05%
Sales Growth (5Y)
+1.29%
EPS Est (This Year)
$-0.60
EPS Est (Next Year)
$-0.65
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.93
Price Target Range
Consensus Target: $16.67(8334900.0% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
26.83M
Float
26.71M
Free Float %
99.54%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2016-06-30
Employees
68
CEO
James E. Bradner
Index Membership
—
Website
https://www.syros.com
Syros Pharmaceuticals, Inc. (SYRS) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $5.37K, SYRS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SYRS against other stocks using dozens of fundamental and technical filters.
No, Syros Pharmaceuticals, Inc. (SYRS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Syros Pharmaceuticals, Inc. (SYRS) has a market capitalization of $5,366, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.